⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Steven BaakM.D.

Rheumatology · Bridgeton, MO 63044

NPI: 1598738262

Share:

24

🟡 Moderate

Risk Flags

High opioid rate vs specialty peersElevated cost per beneficiaryHigh long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

22,823

Total Claims

$10.4M

Drug Cost

1,718

Beneficiaries

$6,061

Cost/Patient

Risk Score Breakdown 24/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+10
Long-acting opioid rate+8
Cost per patient outlier+3

Score components are additive. Read full methodology

Peer Comparison vs. 5,101 Rheumatology providers

+416%

Opioid rate vs peers

21.0% vs 4.1% avg

0%

Cost per patient vs peers

$6,061 vs $6,039 avg

+42%

Brand preference vs peers

10.8% vs 7.6% avg

🔎 Data Overview

💊

Opioid rate is 416% above Rheumatology peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

21.0%

Opioid Rate

4,784

Opioid Claims

$110K

Opioid Cost

16.3%

Long-Acting Rate

This provider's opioid prescribing rate of 21.0% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

89% generic

Brand: 2,448 claims · $9.9M

Generic: 20,273 claims · $547K

Patient Profile

70

Avg Age

74%

Female

1.86

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About